| 1 |
20176717 | Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure. | 2010 May |
2 |
| 2 |
19358945 | Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure. | 2009 Apr 14 |
1 |
| 3 |
15627648 | Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. | 2005 May |
1 |
| 4 |
15023890 | Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. | 2004 Apr 6 |
1 |
| 5 |
11864932 | Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition. | 2002 Feb 26 |
1 |
| 6 |
11079680 | Subcutaneous administration of brain natriuretic peptide in experimental heart failure. | 2000 Nov 1 |
1 |
| 7 |
9140004 | BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. | 1997 Apr |
3 |
| 8 |
8285286 | Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction. | 1993 Dec |
4 |
| 9 |
1864303 | Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney. | 1991 Jun 6 |
2 |
| 10 |
2150207 | Effects of brain natriuretic peptide on hemodynamics and renal function in dogs. | 1990 |
1 |